| [1] |
SU Ya, ZHANG Dongwei, YU Minghui, WANG Chunhua, WU Yueyue.
Observation on the clinical efficacy of compound kushen injection combined with targeted and immune therapy in the treatment of advanced hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2026, 54(3): 324-328.
|
| [2] |
CHEN Minchun, XUE Runqing, ZHAO Xin, ZHANG Meng, YE Dan, ZHANG Jingyi, ZHENG Jie.
Development and evaluation of the tumor vaccine TCL/CpG@GNP
[J]. Tianjin Medical Journal, 2025, 53(10): 1021-1026.
|
| [3] |
XU Tong, ZHANG Wei, LIU Yonghui.
Research progress of dendritic cell exosomes as vaccine carriers
[J]. Tianjin Medical Journal, 2025, 53(10): 1115-1120.
|
| [4] |
ZHANG Lanying, ZHANG Fuan, LIU Maomao, CHEN Jie, ZHOU Jian, LIU Yuting, OUYANG Yao.
Distribution and significance of CD1a+ and CD83+ dendritic cells in lung tissue of COPD mice
[J]. Tianjin Medical Journal, 2024, 52(9): 913-916.
|
| [5] |
DING Yuxiao, SU Jingxi, SONG Qiong, WANG Lihui, WU Ribao, KUANG Xinyu, SU Ying, ZOU Chunlin.
Effect of intra-striatal injection of α-Synuclein PFF on pathological changes of olfactory bulb in macaca fascicularis
[J]. Tianjin Medical Journal, 2023, 51(6): 586-589.
|
| [6] |
WANG Yingying.
Analysis of the effect of sublingual immunotherapy for allergic rhinitis in children and judgment of obvious effect time
[J]. Tianjin Medical Journal, 2023, 51(11): 1255-1257.
|
| [7] |
LI Xiyuan, ZHU Zhixin, ZHAO Hailong .
Recent advances in the mechanisms of drug resistance and treatment of
BRAF-mutant melanoma
[J]. Tianjin Medical Journal, 2022, 50(2): 214-219.
|
| [8] |
LEI Xiaomei, QU Jiaquan, TAN Tan .
Progress in clinical trials of PD-1 inhibitor monoclonal antibody for nasopharyngeal carcinoma
[J]. Tianjin Medical Journal, 2022, 50(2): 220-224.
|
| [9] |
YANG Wuxia, LIU Baoshan, WU Yuhong, LI Runjie, WANG Mengxiao, WANG Aidi.
The effect of Xijiao Dihuang combined prescription on T cell differentiation induced by platelet antigen loaded DC in ITP patients
[J]. Tianjin Medical Journal, 2022, 50(12): 1233-1238.
|
| [10] |
YU Xian-zhe, ZHU Ling-ling, LI Jian-guo.
Vascular normalization and immunotherapy in hepatocellular carcinoma #br#
[J]. Tianjin Medical Journal, 2021, 49(2): 219-224.
|
| [11] |
LUO Yan-fen, ZHUANG Qi-zhen, ZHANG Xuan, CHEN Cha, LIU Yang, YAN Xing-xing, XIAO Qian, LI You-qiang.
3-O-C12-HSL hampers the maturation of Mo-DCs by inhibiting the expression of
lncRNA CD48-AS and CD48
[J]. Tianjin Medical Journal, 2021, 49(12): 1233-1239.
|
| [12] |
YOU Xiang-yun, , XIANG Zhen-dong, YI Cheng, ZHANG Man, YU Jun-feng△.
Advances in the treatment of prostate cancer by chimeric antigen receptor modified T cells
[J]. Tianjin Medical Journal, 2020, 48(10): 1020-1024.
|
| [13] |
ZHAO Pei-qi, ZHANG Hui-lai.
Research progress of chimeric antigen receptor T cell immunotherapy in
B-cell non-Hodgkin lymphoma
[J]. Tianjin Medical Journal, 2020, 48(1): 71-75.
|
| [14] |
ZHANG Hong-xia1, REN Chun-e2, WANG Xiao-jing1, ZHANG Yong1, WANG Gui-li2△.
Expressions of SIRT1, SIRT2 and IL-37 in ectopic endometrium of patients with endometriosis
[J]. Tianjin Med J, 2019, 47(4): 425-427.
|
| [15] |
ZHANG Hui-li, MU Yan-xi, TIAN Yu, YANG Li-qun, WANG Lin.
Expression and clinical significance of Panx 1 in non-small cell lung cancer
[J]. Tianjin Medical Journal, 2019, 47(3): 273-276.
|